世界の疼痛管理用治療薬市場予測2023-2029：ジェネリックオピオイド薬、ブランドオピオイド薬、NSAID、その他

【英語タイトル】Drugs for Pain Management Market, Global Outlook and Forecast 2023-2029

・商品コード：MMG23LY8495
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：108
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア

◆販売価格オプション（消費税別）

Single User（1名様閲覧用）	USD3,250 ⇒換算￥494,000	見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）	USD4,225 ⇒換算￥642,200	見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）	USD4,875 ⇒換算￥741,000	見積依頼/購入/質問フォーム

※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）

❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の疼痛管理用治療薬市場規模と予測を収録しています。・世界の疼痛管理用治療薬市場：売上、2018年-2023年、2024年-2029年
・世界の疼痛管理用治療薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の疼痛管理用治療薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「ジェネリックオピオイド薬」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

疼痛管理用治療薬のグローバル主要企業は、GSK、 Pfizer、 Grunenthal、 Sanofi、 Bayer、 AstraZeneca、 Eli Lilly、 Endo、 Merck、 Yunnan Baiyao、 Teikoku Seiyaku、 Teva、 J&J、 Assertio Therapeutics、 Allerganなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、疼痛管理用治療薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の疼痛管理用治療薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の疼痛管理用治療薬市場：タイプ別市場シェア、2022年
・ジェネリックオピオイド薬、ブランドオピオイド薬、NSAID、その他

世界の疼痛管理用治療薬市場：用途別、2018年-2023年、2024年-2029年
世界の疼痛管理用治療薬市場：用途別市場シェア、2022年
・病院、ドラッグストア、その他

世界の疼痛管理用治療薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の疼痛管理用治療薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における疼痛管理用治療薬のグローバル売上、2018年-2023年
・主要企業における疼痛管理用治療薬のグローバル売上シェア、2022年
・主要企業における疼痛管理用治療薬のグローバル販売量、2018年-2023年
・主要企業における疼痛管理用治療薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
GSK、 Pfizer、 Grunenthal、 Sanofi、 Bayer、 AstraZeneca、 Eli Lilly、 Endo、 Merck、 Yunnan Baiyao、 Teikoku Seiyaku、 Teva、 J&J、 Assertio Therapeutics、 Allergan

*************************************************************

・調査・分析レポートの概要
疼痛管理用治療薬市場の定義
市場セグメント
世界の疼痛管理用治療薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の疼痛管理用治療薬市場規模
世界の疼痛管理用治療薬市場規模：2022年 VS 2029年
世界の疼痛管理用治療薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの疼痛管理用治療薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の疼痛管理用治療薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：ジェネリックオピオイド薬、ブランドオピオイド薬、NSAID、その他
疼痛管理用治療薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：病院、ドラッグストア、その他
疼痛管理用治療薬の用途別グローバル売上・予測

・地域別市場分析
地域別疼痛管理用治療薬市場規模 2022年と2029年
地域別疼痛管理用治療薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
GSK、 Pfizer、 Grunenthal、 Sanofi、 Bayer、 AstraZeneca、 Eli Lilly、 Endo、 Merck、 Yunnan Baiyao、 Teikoku Seiyaku、 Teva、 J&J、 Assertio Therapeutics、 Allergan
...

Pain is complex, so there are many treatment options — medications, therapies, and mind-body techniques.
This report is mainly about the drugs for pain management.
This report aims to provide a comprehensive presentation of the global market for Drugs for Pain Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Pain Management. This report contains market size and forecasts of Drugs for Pain Management in global, including the following market information:
Global Drugs for Pain Management Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Drugs for Pain Management market was valued at US$ 36380 million in 2022 and is projected to reach US$ 42650 million by 2029, at a CAGR of 2.3% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The leading manufacturers in the industry are GSK, Pfizer and Grunenthal, which accounted for 14.42%, 13.95% and 3.92% of revenues in 2019. By region, the U.S. has the highest share of income, at 49.67 percent in 2019.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Drugs for Pain Management companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Drugs for Pain Management Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Pain Management Market Segment Percentages, by Type, 2022 (%)
Generic Opioid
Branded Opioids
NSAIDs
Others
Global Drugs for Pain Management Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Drugs for Pain Management Market Segment Percentages, by Application, 2022 (%)
Hospitals
Drugstores
Others
Global Drugs for Pain Management Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Drugs for Pain Management Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Drugs for Pain Management revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Drugs for Pain Management revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
GSK
Pfizer
Grunenthal
Sanofi
Bayer
AstraZeneca
Eli Lilly
Endo
Merck
Yunnan Baiyao
Teikoku Seiyaku
Teva
J&J
Assertio Therapeutics
Allergan
Outline of Major Chapters:
Chapter 1: Introduces the definition of Drugs for Pain Management, market overview.
Chapter 2: Global Drugs for Pain Management market size in revenue.
Chapter 3: Detailed analysis of Drugs for Pain Management company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Drugs for Pain Management in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Drugs for Pain Management Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Drugs for Pain Management Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Drugs for Pain Management Overall Market Size
2.1 Global Drugs for Pain Management Market Size: 2022 VS 2029
2.2 Global Drugs for Pain Management Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Drugs for Pain Management Players in Global Market
3.2 Top Global Drugs for Pain Management Companies Ranked by Revenue
3.3 Global Drugs for Pain Management Revenue by Companies
3.4 Top 3 and Top 5 Drugs for Pain Management Companies in Global Market, by Revenue in 2022
3.5 Global Companies Drugs for Pain Management Product Type
3.6 Tier 1, Tier 2 and Tier 3 Drugs for Pain Management Players in Global Market
3.6.1 List of Global Tier 1 Drugs for Pain Management Companies
3.6.2 List of Global Tier 2 and Tier 3 Drugs for Pain Management Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Drugs for Pain Management Market Size Markets, 2022 & 2029
4.1.2 Generic Opioid
4.1.3 Branded Opioids
4.1.4 NSAIDs
4.1.5 Others
4.2 By Type – Global Drugs for Pain Management Revenue & Forecasts
4.2.1 By Type – Global Drugs for Pain Management Revenue, 2018-2023
4.2.2 By Type – Global Drugs for Pain Management Revenue, 2024-2029
4.2.3 By Type – Global Drugs for Pain Management Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Drugs for Pain Management Market Size, 2022 & 2029
5.1.2 Hospitals
5.1.3 Drugstores
5.1.4 Others
5.2 By Application – Global Drugs for Pain Management Revenue & Forecasts
5.2.1 By Application – Global Drugs for Pain Management Revenue, 2018-2023
5.2.2 By Application – Global Drugs for Pain Management Revenue, 2024-2029
5.2.3 By Application – Global Drugs for Pain Management Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Drugs for Pain Management Market Size, 2022 & 2029
6.2 By Region – Global Drugs for Pain Management Revenue & Forecasts
6.2.1 By Region – Global Drugs for Pain Management Revenue, 2018-2023
6.2.2 By Region – Global Drugs for Pain Management Revenue, 2024-2029
6.2.3 By Region – Global Drugs for Pain Management Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Drugs for Pain Management Revenue, 2018-2029
6.3.2 US Drugs for Pain Management Market Size, 2018-2029
6.3.3 Canada Drugs for Pain Management Market Size, 2018-2029
6.3.4 Mexico Drugs for Pain Management Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Drugs for Pain Management Revenue, 2018-2029
6.4.2 Germany Drugs for Pain Management Market Size, 2018-2029
6.4.3 France Drugs for Pain Management Market Size, 2018-2029
6.4.4 U.K. Drugs for Pain Management Market Size, 2018-2029
6.4.5 Italy Drugs for Pain Management Market Size, 2018-2029
6.4.6 Russia Drugs for Pain Management Market Size, 2018-2029
6.4.7 Nordic Countries Drugs for Pain Management Market Size, 2018-2029
6.4.8 Benelux Drugs for Pain Management Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Drugs for Pain Management Revenue, 2018-2029
6.5.2 China Drugs for Pain Management Market Size, 2018-2029
6.5.3 Japan Drugs for Pain Management Market Size, 2018-2029
6.5.4 South Korea Drugs for Pain Management Market Size, 2018-2029
6.5.5 Southeast Asia Drugs for Pain Management Market Size, 2018-2029
6.5.6 India Drugs for Pain Management Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Drugs for Pain Management Revenue, 2018-2029
6.6.2 Brazil Drugs for Pain Management Market Size, 2018-2029
6.6.3 Argentina Drugs for Pain Management Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Drugs for Pain Management Revenue, 2018-2029
6.7.2 Turkey Drugs for Pain Management Market Size, 2018-2029
6.7.3 Israel Drugs for Pain Management Market Size, 2018-2029
6.7.4 Saudi Arabia Drugs for Pain Management Market Size, 2018-2029
6.7.5 UAE Drugs for Pain Management Market Size, 2018-2029
7 Drugs for Pain Management Companies Profiles
7.1 GSK
7.1.1 GSK Company Summary
7.1.2 GSK Business Overview
7.1.3 GSK Drugs for Pain Management Major Product Offerings
7.1.4 GSK Drugs for Pain Management Revenue in Global Market (2018-2023)
7.1.5 GSK Key News & Latest Developments
7.2 Pfizer
7.2.1 Pfizer Company Summary
7.2.2 Pfizer Business Overview
7.2.3 Pfizer Drugs for Pain Management Major Product Offerings
7.2.4 Pfizer Drugs for Pain Management Revenue in Global Market (2018-2023)
7.2.5 Pfizer Key News & Latest Developments
7.3 Grunenthal
7.3.1 Grunenthal Company Summary
7.3.2 Grunenthal Business Overview
7.3.3 Grunenthal Drugs for Pain Management Major Product Offerings
7.3.4 Grunenthal Drugs for Pain Management Revenue in Global Market (2018-2023)
7.3.5 Grunenthal Key News & Latest Developments
7.4 Sanofi
7.4.1 Sanofi Company Summary
7.4.2 Sanofi Business Overview
7.4.3 Sanofi Drugs for Pain Management Major Product Offerings
7.4.4 Sanofi Drugs for Pain Management Revenue in Global Market (2018-2023)
7.4.5 Sanofi Key News & Latest Developments
7.5 Bayer
7.5.1 Bayer Company Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer Drugs for Pain Management Major Product Offerings
7.5.4 Bayer Drugs for Pain Management Revenue in Global Market (2018-2023)
7.5.5 Bayer Key News & Latest Developments
7.6 AstraZeneca
7.6.1 AstraZeneca Company Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Drugs for Pain Management Major Product Offerings
7.6.4 AstraZeneca Drugs for Pain Management Revenue in Global Market (2018-2023)
7.6.5 AstraZeneca Key News & Latest Developments
7.7 Eli Lilly
7.7.1 Eli Lilly Company Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly Drugs for Pain Management Major Product Offerings
7.7.4 Eli Lilly Drugs for Pain Management Revenue in Global Market (2018-2023)
7.7.5 Eli Lilly Key News & Latest Developments
7.8 Endo
7.8.1 Endo Company Summary
7.8.2 Endo Business Overview
7.8.3 Endo Drugs for Pain Management Major Product Offerings
7.8.4 Endo Drugs for Pain Management Revenue in Global Market (2018-2023)
7.8.5 Endo Key News & Latest Developments
7.9 Merck
7.9.1 Merck Company Summary
7.9.2 Merck Business Overview
7.9.3 Merck Drugs for Pain Management Major Product Offerings
7.9.4 Merck Drugs for Pain Management Revenue in Global Market (2018-2023)
7.9.5 Merck Key News & Latest Developments
7.10 Yunnan Baiyao
7.10.1 Yunnan Baiyao Company Summary
7.10.2 Yunnan Baiyao Business Overview
7.10.3 Yunnan Baiyao Drugs for Pain Management Major Product Offerings
7.10.4 Yunnan Baiyao Drugs for Pain Management Revenue in Global Market (2018-2023)
7.10.5 Yunnan Baiyao Key News & Latest Developments
7.11 Teikoku Seiyaku
7.11.1 Teikoku Seiyaku Company Summary
7.11.2 Teikoku Seiyaku Business Overview
7.11.3 Teikoku Seiyaku Drugs for Pain Management Major Product Offerings
7.11.4 Teikoku Seiyaku Drugs for Pain Management Revenue in Global Market (2018-2023)
7.11.5 Teikoku Seiyaku Key News & Latest Developments
7.12 Teva
7.12.1 Teva Company Summary
7.12.2 Teva Business Overview
7.12.3 Teva Drugs for Pain Management Major Product Offerings
7.12.4 Teva Drugs for Pain Management Revenue in Global Market (2018-2023)
7.12.5 Teva Key News & Latest Developments
7.13 J&J
7.13.1 J&J Company Summary
7.13.2 J&J Business Overview
7.13.3 J&J Drugs for Pain Management Major Product Offerings
7.13.4 J&J Drugs for Pain Management Revenue in Global Market (2018-2023)
7.13.5 J&J Key News & Latest Developments
7.14 Assertio Therapeutics
7.14.1 Assertio Therapeutics Company Summary
7.14.2 Assertio Therapeutics Business Overview
7.14.3 Assertio Therapeutics Drugs for Pain Management Major Product Offerings
7.14.4 Assertio Therapeutics Drugs for Pain Management Revenue in Global Market (2018-2023)
7.14.5 Assertio Therapeutics Key News & Latest Developments
7.15 Allergan
7.15.1 Allergan Company Summary
7.15.2 Allergan Business Overview
7.15.3 Allergan Drugs for Pain Management Major Product Offerings
7.15.4 Allergan Drugs for Pain Management Revenue in Global Market (2018-2023)
7.15.5 Allergan Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables
Table 1. Drugs for Pain Management Market Opportunities & Trends in Global Market
Table 2. Drugs for Pain Management Market Drivers in Global Market
Table 3. Drugs for Pain Management Market Restraints in Global Market
Table 4. Key Players of Drugs for Pain Management in Global Market
Table 5. Top Drugs for Pain Management Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Drugs for Pain Management Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Drugs for Pain Management Revenue Share by Companies, 2018-2023
Table 8. Global Companies Drugs for Pain Management Product Type
Table 9. List of Global Tier 1 Drugs for Pain Management Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Drugs for Pain Management Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Drugs for Pain Management Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Drugs for Pain Management Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Drugs for Pain Management Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application – Global Drugs for Pain Management Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Drugs for Pain Management Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Drugs for Pain Management Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region – Global Drugs for Pain Management Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Drugs for Pain Management Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Drugs for Pain Management Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Drugs for Pain Management Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Drugs for Pain Management Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Drugs for Pain Management Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Drugs for Pain Management Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Drugs for Pain Management Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Drugs for Pain Management Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Drugs for Pain Management Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Drugs for Pain Management Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Drugs for Pain Management Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Drugs for Pain Management Revenue, (US$, Mn), 2024-2029
Table 30. GSK Company Summary
Table 31. GSK Drugs for Pain Management Product Offerings
Table 32. GSK Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 33. GSK Key News & Latest Developments
Table 34. Pfizer Company Summary
Table 35. Pfizer Drugs for Pain Management Product Offerings
Table 36. Pfizer Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 37. Pfizer Key News & Latest Developments
Table 38. Grunenthal Company Summary
Table 39. Grunenthal Drugs for Pain Management Product Offerings
Table 40. Grunenthal Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 41. Grunenthal Key News & Latest Developments
Table 42. Sanofi Company Summary
Table 43. Sanofi Drugs for Pain Management Product Offerings
Table 44. Sanofi Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 45. Sanofi Key News & Latest Developments
Table 46. Bayer Company Summary
Table 47. Bayer Drugs for Pain Management Product Offerings
Table 48. Bayer Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Key News & Latest Developments
Table 50. AstraZeneca Company Summary
Table 51. AstraZeneca Drugs for Pain Management Product Offerings
Table 52. AstraZeneca Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 53. AstraZeneca Key News & Latest Developments
Table 54. Eli Lilly Company Summary
Table 55. Eli Lilly Drugs for Pain Management Product Offerings
Table 56. Eli Lilly Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 57. Eli Lilly Key News & Latest Developments
Table 58. Endo Company Summary
Table 59. Endo Drugs for Pain Management Product Offerings
Table 60. Endo Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 61. Endo Key News & Latest Developments
Table 62. Merck Company Summary
Table 63. Merck Drugs for Pain Management Product Offerings
Table 64. Merck Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 65. Merck Key News & Latest Developments
Table 66. Yunnan Baiyao Company Summary
Table 67. Yunnan Baiyao Drugs for Pain Management Product Offerings
Table 68. Yunnan Baiyao Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 69. Yunnan Baiyao Key News & Latest Developments
Table 70. Teikoku Seiyaku Company Summary
Table 71. Teikoku Seiyaku Drugs for Pain Management Product Offerings
Table 72. Teikoku Seiyaku Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 73. Teikoku Seiyaku Key News & Latest Developments
Table 74. Teva Company Summary
Table 75. Teva Drugs for Pain Management Product Offerings
Table 76. Teva Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 77. Teva Key News & Latest Developments
Table 78. J&J Company Summary
Table 79. J&J Drugs for Pain Management Product Offerings
Table 80. J&J Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 81. J&J Key News & Latest Developments
Table 82. Assertio Therapeutics Company Summary
Table 83. Assertio Therapeutics Drugs for Pain Management Product Offerings
Table 84. Assertio Therapeutics Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 85. Assertio Therapeutics Key News & Latest Developments
Table 86. Allergan Company Summary
Table 87. Allergan Drugs for Pain Management Product Offerings
Table 88. Allergan Drugs for Pain Management Revenue (US$, Mn) & (2018-2023)
Table 89. Allergan Key News & Latest Developments
List of Figures
Figure 1. Drugs for Pain Management Segment by Type in 2022
Figure 2. Drugs for Pain Management Segment by Application in 2022
Figure 3. Global Drugs for Pain Management Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Drugs for Pain Management Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Drugs for Pain Management Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Drugs for Pain Management Revenue in 2022
Figure 8. By Type - Global Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 9. By Application - Global Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 10. By Type - Global Drugs for Pain Management Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 12. By Application - Global Drugs for Pain Management Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 14. By Region - Global Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 15. By Country - North America Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 16. US Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 20. Germany Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 21. France Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 28. China Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 32. India Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 34. Brazil Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Drugs for Pain Management Revenue Market Share, 2018-2029
Figure 37. Turkey Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Drugs for Pain Management Revenue, (US$, Mn), 2018-2029
Figure 41. GSK Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Pfizer Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Grunenthal Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Sanofi Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. AstraZeneca Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Eli Lilly Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Endo Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Merck Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Yunnan Baiyao Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Teikoku Seiyaku Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Teva Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. J&J Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Assertio Therapeutics Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Allergan Drugs for Pain Management Revenue Year Over Year Growth (US$, Mn) & (2018-2023)

★調査レポート[世界の疼痛管理用治療薬市場予測2023-2029：ジェネリックオピオイド薬、ブランドオピオイド薬、NSAID、その他] (コード：MMG23LY8495)販売に関する免責事項を必ずご確認ください。

★調査レポート[世界の疼痛管理用治療薬市場予測2023-2029：ジェネリックオピオイド薬、ブランドオピオイド薬、NSAID、その他]についてメールでお問い合わせ

MarketReport.jp

世界の疼痛管理用治療薬市場予測2023-2029：ジェネリックオピオイド薬、ブランドオピオイド薬、NSAID、その他

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料 総合販売サイト www.MarketReport.jp

市場調査レポート・産業資料総合販売サイト www.MarketReport.jp